Discovery
From Nose to Nerves: World-First Clinical Trial Puts Stem Cells in the Spotlight for Spinal Cord Injury
2025-08-28
Eli Lilly’s Oral GLP-1 Weight-Loss Pill Clears Third Phase 3 Trial, Bringing FDA Approval Within Reach
2025-08-27
FDA Grants First Approval for Wegovy to Treat MASH with Liver Fibrosis, Backed by Positive Phase 3 Trial
2025-08-17
FDA Approval of First-in-Class BRINSUPRI Offers New Hope for Hundreds of Thousands with Chronic Lung Disease
2025-08-12
2025 Alzheimer’s Drug Development: From Anti-Amyloid to Next-Gen Targets and a $15.5B Market Opportunity
2025-08-11
Novartis Secures Approval for First-Ever Malaria Treatment Designed for Newborns After a Decade of Research
2025-07-09
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea



